CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
44 hedge funds and large institutions have $18.9M invested in CASI Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
64% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 14
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$245K | |
| 2 | +$106K | |
| 3 | +$76.3K | |
| 4 |
Citigroup
New York
|
+$57.4K |
| 5 |
VF
Virtu Financial
New York
|
+$25.1K |
Top Sellers
| 1 | -$1.34M | |
| 2 | -$1.02M | |
| 3 | -$620K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$241K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$214K |